John Smith Clark II

John Smith Clark II has an estimated net worth of $81.8 Million. This is based on reported shares across multiple companies, which include Lev Pharmaceuticals Inc, FENNEC PHARMACEUTICALS INC., NEXMED INC, NeoStem, Inc., INTEGRATED ELECTRICAL SERVICES INC, AMARIN CORP PLC, and IXI Mobile, Inc..

2007 was John Smith Clark II's most active year for acquiring shares with 4 total transactions. John Smith Clark II's most active month to acquire stocks was the month of December. 2025 was John Smith Clark II's most active year for disposing of shares, totalling 7 transactions. John Smith Clark II's most active month to dispose stocks was the month of May. 2007 saw John Smith Clark II paying a total of $1,702,724.40 for 133,700 shares, this is the most they've acquired in one year. In 2007 John Smith Clark II cashed out on 2,900,102 shares for a total of $43,902,244.00, their largest year based on trade value.